CN Stock MarketDetailed Quotes

300463 Maccura Biotechnology

Watchlist
  • 12.55
  • -0.10-0.79%
Market Closed Jun 5 15:00 CST
7.69BMarket Cap24.32P/E (TTM)

About Maccura Biotechnology Company

Since its establishment in 1994, the company has focused on R&D, production, sales and service of in vitro diagnostic products, and is committed to becoming a first-class enterprise in the global diagnostic industry. Since its establishment, the company has always focused on R&D, production, sales and related services of in vitro diagnostic products. The company's main products: biochemical products, immune products, molecular diagnostic products, clinical testing products, rapid testing platforms, pathological product platforms, medical laboratory automation solutions. Corporate honors: Novel coronavirus 2019-nCoV nucleic acid detection kit (fluorescence PCR method), Mike Biotech Enterprise Technology Center was recognized as “National Enterprise Technology Center”, “National Intellectual Property Demonstration Enterprise”, etc.

Company Profile

Short Name-A迈克生物
Symbol-A300463
Company NameMaccura Biotechnology Co., Ltd.
Listing DateMay 28, 2015
Issue Price27.96
Shares Offered46.50M share(s)
FoundedOct 20, 1994
Legal Representativeyong tang
General Managermingjian wu
Secretarywei shi
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativewenjun zhang
Legal CounselShanghai AllBright Law Firm
Employees1142
Phone028-81731186
Office AddressNo. 8, Anhe 2nd Road, High-tech Zone, Chengdu, Sichuan
Zip Code611730
Registered AddressNo. 16 Baichuan Road, High-tech Zone, Chengdu, Sichuan
Fax028-81731188
Emailzqb@maccura.com
Business License510000000104554
BusinessLicense items: Class II medical device production; Class III medical device production; Class III medical device management; Class III medical device leasing; disinfection equipment sales; road cargo transportation (excluding dangerous goods); medical device Internet information services; General projects: Class I medical device production; Class I medical device sales; Sales of hygiene products and disposable medical products; Sales of laboratory analytical instruments; Class I medical device leasing; Class II medical device leasing; special equipment repair; manufacture of specialty chemical products (excluding hazardous chemicals); specialty chemistry Product sales (excluding hazardous chemicals); plastic product manufacturing; plastic product sales; mechanical parts, parts sales; computer software, hardware and auxiliary equipment wholesale; information system integration services; office equipment sales; sales of office equipment consumables; market research (excluding external investigation); domestic trade agency; general cargo warehousing services (excluding hazardous chemicals and other items requiring licensing); engineering and technical research and test development; biochemical product technology research and development; technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion; import and export of goods ; Technology import and export. (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license).

Company Executives

  • Name
  • Position
  • Salary
  • yong tang
  • Chairman,directors,Member of the Strategy Committee,Member of the Remuneration and Assessment Committee,Nomination Committee Members,Audit Committee Member
  • 1.30M
  • qilin liu
  • directors,Member of the Strategy Committee
  • 705.30K
  • mingjian wu
  • directors,general manager,Member of the Strategy Committee
  • 1.31M
  • shan yin
  • directors,Chief Financial Officer
  • 843.60K
  • hui yang
  • directors,Director of Production
  • 742.90K
  • dengming wang
  • directors,Member of the Strategy Committee,Nomination Committee Members,Director of Commerce
  • 733.80K
  • daiguo fu
  • Independent directors,Nomination Committee Members,Audit Committee Member,Member of the Remuneration and Assessment Committee
  • 100.00K
  • zhenzhong liao
  • Independent directors,Audit Committee Member,Member of the Remuneration and Assessment Committee,Member of the Strategy Committee,Nomination Committee Members
  • 100.00K
  • kaicheng liang
  • Independent directors,Audit Committee Member,Member of the Remuneration and Assessment Committee,Nomination Committee Members
  • 100.00K
  • wei shi
  • Board Secretary,Director of Strategic Investments
  • 820.10K
  • wenjun zhang
  • Securities affairs representative
  • --
  • yuan zou
  • Chairman of the Supervisory Board,auditors
  • 47.60K
  • hong deng
  • auditors
  • 476.60K
  • ping yu
  • Executive Director
  • 757.50K
  • zhen wang
  • Director of Production
  • 712.50K
  • weijia wang
  • Director of R&D
  • 933.20K
  • tengxiang long
  • Director of R&D
  • 938.70K
  • lin wang
  • Employee supervisors
  • 424.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg